ACCP Research Institute - Community Advisory Panel

Community Advisory Panel

The CAP is a standing committee to the ACCP PBRN with the mission to represent the breadth and depth of PBRN members. In addition, the CAP will be utilized as a mechanism for readily available feedback regarding the feasibility and practicality of proposed research projects. To apply for the ACCP PBRN Community Advisory Panel, click here.

	Brian R. Overholser, Pharm.D. (Chair) Assistant Professor broverho@iupui.edu School of Pharmacy and Pharmaceutical Sciences Purdue University Specialties: Cardiovascular, Pharmacokinetics/Pharmacodynamics Dr. Overholser’s research program is focused on preventative strategies for arrhythmia development by the manipulation of novel drug targets. He teaches in the professional and graduate programs at Purdue University on cardiovascular disease, pharmacokinetics, and pharmacometrics. He also serves Wishard Hospital in Indianapolis, Indiana as a clinical pharmacist on an internal medicine service. The most impactful projects that I have been involved with have come from clinical and practice-based observations. Therefore, I have a strong interest in promoting translational research through the rich and diverse membership of the ACCP PBRN. I am honored to have the opportunity to serve as chair of the inaugural Community Advisory Panel and utilize my previous experience conducting clinical trials and translational research to serve the PBRN.
	Edith A. Nutescu, Pharm.D., FCCP (Vice-Chair) Clinical Professor Department of Pharmacy Practice & Center for Pharmacoeconomic Research The University of Illinois at Chicago, College of Pharmacy Specialties: Health Outcomes, Cardiovascular Dr. Nutescu maintains an active clinical practice and research program. Her research and practice interests are in the areas of comparative effectiveness, health services and outcomes, with emphasis in cardiovascular diseases, stroke, thrombosis, and antithrombotic therapies. My involvement in projects that demonstrated the benefit of phamacists' services and interventions have been most rewarding in my clinical and research career. I have a strong interest in promoting health services and comparative effectiveness research that will further highlight the strenghts of our profession. The ACCP PBRN is the perfect venue to launch such projects. I am honored to serve as the vice-chair of the inaugural Community Advisory Panel and utilize my previous experience in clinical and health services research to serve the PBRN.
	Lori Dickerson, PharmD, FCCP, BCPS (Member) Professor of Family Medicine Medical University of South Carolina Associate Residency Program Director Trident/MUSC Family Medicine Residency Program Specialty: Education I am serving on the CAP because I am on the executive committee for the National Interdisciplinary Primary Care PBRN, currently undertaking an NIH-funded grant to study collaborative hypertension management. I am involved in the I3 collaborative, a PBRN of family medicine residency programs in the Southeast, focusing on chronic care and the patient centered medical home. I have also served as the clinical pharmacist for the Practice Partner Research Network (PPRNet), a PBRN using the Practice Partner medical record.
	Christopher R. Frei, Pharm.D., M.Sc., BCPS (Member) Assistant Professor, Pharmacotherapy Division College of Pharmacy, The University of Texas at Austin Clinical Assistant Professor Department of Medicine, Division of Infectious Diseases and Pharmacotherapy Education & Research Center School of Medicine, The University of Texas Health Science Center at San Antonio Specialties: Practice-Based Research; Infectious Disease ACCP's PBRN has the potential to transform medication-related research by bringing together pharmacists from practice and research settings to achieve a common goal; to improve human health. The PBRN will faciliate communication and collaboration among its partners. This will enable more meaningful projects, with greater societal impact than independent clinicans or researchers could ever achieve alone. The PBRN will become a major source of new medication-related knowledge and the vast network will enable unprecendented dissemination of that knowledge to the practitioners who will apply it and thereby transform our health care systems.
	Janelle Perkins, PharmD, BCOP (Member) Assistant Member Blood and Marrow Transplant Program, H. Lee Moffitt Cancer Center Assistant Professor of Oncologic Sciences College of Medicine, University of South Florida Specialty: Oncology/Blood and Marrow Transplantation My current position is 100% clinical research in the area of blood/marrow transplantation for adult hematologic malignancies. I volunteered to serve on the CAP in order to help ACCP promote pharmacy practice based research as I feel this is an incredibly rewarding facet of our profession. We have much to offer when it comes to advancing the care of our patients when we are involved in clinical research and I think ACCP has taken significant strides in providing a platform for that participation.
	David S. Hoff, Pharm.D. (Member) Clinical Coordinator - Critical Care Children's Hospitals and Clinics of Minnesota Specialties: Pediatrics; Pediatric and Neonatal Critical Care It is an exciting time to be serving in the ACCP PBRN and CAP. As an organization, we are at the point of launching a significant initiative where we will bring the well-known research strength of the ACCP membership to bear on the clinical pharmacy issues of our time. I am pleased to be a part of the formative work in shaping this new program. I will be adding to the diversity of the CAP by bringing pediatric and neonatal expertise to the discussion. I have also had experience in retail pharmacy and pharmacy benefit management in my career that will give me a broader perspective on research study proposals.
	Orly Vardeny, Pharm.D. (Member) Assistant Professor of Pharmacy University of Wisconsin Specialties: Cardiovascular; Heart Failure PBRN/CAP is an exciting prospect to advance the pharmacy field by developing collaborative research opportunities. It is an honor to be involved in the initial planning of what is sure to be a successful endeavor.
	Nathan Painter, Pharm.D., CDE (Member) Assistant Clinical Professor UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences Specialty: Clinical – Diabetes, HTN, lipids, Medicare Part D I joined the PBRN because I recognized the need for a broad based research network whose ultimate goal is to show the value of clinical pharmacy and see pharmacy one step closer to reaching provider status with CMS. The Community Advisory Board interested me because it is a unique opportunity to shape a project from the ground up with a grassroots approach. I hope to be able to provide valuable feedback as to the feasibility of the PBRN’s projects.
	S. Diane Goodwin, Pharm.D., FCCP (Member) Clinical Pharmacist Duke University Hospital Specialty: Infectious Diseases The PBRN is an innovative mechanism for ACCP members to contribute to the advancement of knowledge, in conjunction with providing clinical patient care. I volunteered to serve on the CAP to help establish the groundwork for this initiative. Specifically, I hope to contribute my experience with collaborative research, including investigator-initiated research and research with government agencies at two pharmaceutical companies, to facilitate the work of the PBRN and CAP. I look forward to the initiation of PBRN research programs.